These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Estudio clínico de fase IIa, del tratamiento con heparina topica en pacientes con sindrome eritrodisestesico palmo-plantar asociado a capecitabina
|Completed, but no date, and reported results
|Neurotoxicity characterization phase II randomized study of nab-paclitaxel versus conventional paclitaxel as first-line therapy of metastatic HER2-negative breast cancer. Ensayo fase II randomizado...